相关实验视频
Updated: Jun 27, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.4K
在未经治疗的高血压患者中,原发性阿尔多斯特主义的目标器官损伤
Shi-Min Li1, Jia-Yi Huang1,2, Ching-Yan Zhu2
1Division of Cardiology, Department of Medicine, The University of Hong Kong- Shenzhen Hospital, Shenzhen, China.
概括
原发性阿尔多斯特隆症 (PA) 与新诊断高血压患者的目标器官损伤 (TOD) 有关. 早期对PA进行查对于管理高血压相关器官损伤至关重要.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 原发性阿尔多斯特主义 (PA) 与目标器官损伤 (TOD) 有关.
- 在新诊断的高血压中,TOD严重程度和PA之间的相关性存在有限的研究.
- 在患有PA的高血压患者中评估TOD具有临床意义.
研究的目的:
- 在新诊断的高血压患者中评估PA和TOD之间的关联.
- 为了比较高血压患者与没有PA之间的TOD程度.
主要方法:
- 招募了1044名新诊断高血压患者的队列.
- 患者被分为有PA和没有PA的组.
- 收集的数据包括左心室质量指数 (LVMI),心动脉内膜介质厚度 (CIMT),斑块和微专尿.
主要成果:
- 5.5%的患者被诊断出患有PA.
- 在PA患者中,左心室缩,CIMT增加和微专尿的患病率较高.
- 亚血压独立地与增加的LVMI,CIMT和微专尿有关.
结论:
- 新诊断的高血压患者与PA显示更严重的TOD比那些没有PA.
- 血压是高血压中 TOD 的独立风险因素.
- 在新诊断的高血压中查TOD应考虑潜在的PA.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
601
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
601
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Action of β1 Blockers
432
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
432
Antihypertensive Drugs: Potassium-Sparing Diuretics
524
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
524
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
620
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
620

